Geode Capital Management LLC Has $11.43 Million Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

Geode Capital Management LLC lifted its position in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 5.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 507,469 shares of the company's stock after acquiring an additional 27,201 shares during the period. Geode Capital Management LLC owned approximately 1.25% of Phibro Animal Health worth $11,430,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently modified their holdings of the company. Sofinnova Investments Inc. acquired a new stake in Phibro Animal Health in the second quarter valued at about $3,975,000. Barclays PLC boosted its stake in shares of Phibro Animal Health by 25.7% in the 3rd quarter. Barclays PLC now owns 143,337 shares of the company's stock valued at $3,228,000 after purchasing an additional 29,271 shares in the last quarter. Acadian Asset Management LLC grew its holdings in shares of Phibro Animal Health by 6.3% during the 2nd quarter. Acadian Asset Management LLC now owns 717,506 shares of the company's stock valued at $12,027,000 after purchasing an additional 42,299 shares during the last quarter. Algert Global LLC increased its position in Phibro Animal Health by 521.1% during the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company's stock worth $1,606,000 after purchasing an additional 59,850 shares in the last quarter. Finally, BNP Paribas Financial Markets lifted its stake in Phibro Animal Health by 3.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company's stock valued at $548,000 after purchasing an additional 729 shares during the last quarter. Institutional investors and hedge funds own 99.34% of the company's stock.

Phibro Animal Health Trading Up 0.1 %

Phibro Animal Health stock traded up $0.03 during mid-day trading on Wednesday, hitting $21.00. 155,624 shares of the stock were exchanged, compared to its average volume of 160,481. The firm's fifty day simple moving average is $23.12 and its two-hundred day simple moving average is $20.94. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. Phibro Animal Health Co. has a 12 month low of $10.03 and a 12 month high of $25.98. The stock has a market capitalization of $850.56 million, a price-to-earnings ratio of 48.84, a PEG ratio of 0.58 and a beta of 0.51.

Phibro Animal Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th were issued a $0.12 dividend. The ex-dividend date of this dividend was Wednesday, November 27th. This represents a $0.48 annualized dividend and a yield of 2.29%. Phibro Animal Health's payout ratio is 111.63%.

Analysts Set New Price Targets

Several research analysts have recently issued reports on PAHC shares. JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They set a "neutral" rating and a $22.00 price target for the company. Barclays increased their target price on Phibro Animal Health from $13.00 to $20.00 and gave the company an "underweight" rating in a research report on Tuesday, November 12th. Morgan Stanley boosted their price target on Phibro Animal Health from $20.00 to $25.00 and gave the stock an "equal weight" rating in a report on Tuesday, December 17th. Finally, StockNews.com downgraded shares of Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, December 27th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat.com, Phibro Animal Health presently has an average rating of "Hold" and a consensus target price of $20.50.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.